Eliminating Copayments for Skin Cancer Screening-A Public Health Policy With Insufficient Evidence

JAMA Dermatol. 2019 Dec 1;155(12):1339-1340. doi: 10.1001/jamadermatol.2019.2797.

Authors

Adewole S Adamson¹, Michael P Pignone²

Affiliations

¹ Division of Dermatology, Department of Internal Medicine, LIVESTRONG Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin.
² Department of Internal Medicine, LIVESTRONG Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin.

PMID: 31418768
DOI: 10.1001/jamadermatol.2019.2797

No abstract available

MeSH terms

Cost Sharing / legislation & jurisprudence*
Cost Sharing / statistics & numerical data
Early Detection of Cancer / economics*
Early Detection of Cancer / statistics & numerical data
Evidence-Based Medicine / economics
Evidence-Based Medicine / legislation & jurisprudence
Evidence-Based Medicine / statistics & numerical data
Health Plan Implementation
Health Policy / economics*
Health Policy / legislation & jurisprudence
Humans
Illinois
Mass Screening / economics*
Mass Screening / legislation & jurisprudence
Mass Screening / statistics & numerical data
Medical Overuse / economics
Medical Overuse / prevention & control
Patient Protection and Affordable Care Act / economics
Patient Protection and Affordable Care Act / legislation & jurisprudence
Skin Neoplasms / diagnosis*
Skin Neoplasms / economics